Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
about
Improvements in the Management of Diabetic NephropathyPhosphate binders in chronic kidney disease: a systematic review of recent data.Dietary interventions to contrast the onset and progression of diabetic nephropathy: A critical survey of new data.Dietary fat quantity and quality modifies advanced glycation end products metabolism in patients with metabolic syndrome.Uremic Toxicity of Advanced Glycation End Products in CKD.Renal Aging: Causes and Consequences.RAGE and glyoxalase in kidney disease.Diabetic kidney disease: a role for advanced glycation end-product receptor 1 (AGE-R1)?Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis.Effect of PKC-β Signaling Pathway on Expression of MCP-1 and VCAM-1 in Different Cell Models in Response to Advanced Glycation End Products (AGEs).In Silico Analysis of Putrefaction Pathways in Bacteria and Its Implication in Colorectal Cancer.Estrogen receptor subtype ratio change protects against podocyte damage.Sevelamer reduces endothelial inflammatory response to advanced glycation end products.Plasma p-cresol lowering effect of sevelamer in non-dialysis CKD patients: evidence from a randomized controlled trial.Mediterranean Diet Supplemented With Coenzyme Q10 Modulates the Postprandial Metabolism of Advanced Glycation End Products in Elderly Men and Women.Pharmacologic control of oxidative stress and inflammation determines whether diabetic glomerulosclerosis progresses or decreases: A pilot study in sclerosis-prone mice
P2860
Q28080717-C6599B3B-9BD4-45C3-9800-DEAD4E11ACE3Q31039292-E4595900-370E-498A-9631-7D67BF026A19Q31157315-C7A90C72-1F05-44C4-86A6-7C1B65707573Q34680886-264AC993-B576-4DC5-A938-3CD6F38E3722Q36514906-9B049BD5-EAD7-4F21-92DF-3419E4A0B222Q38763576-5D4DF8B5-FB2A-4766-8B36-4A60DBA1D6CAQ38857649-878EE569-A0C2-4176-95C2-8109F0ED1929Q38857652-C1976513-5A0D-441F-B3B8-C1B9296814DDQ39096507-5E3DA25B-7962-4010-828E-DAF0842464D9Q41319436-9A5183CA-9C9E-4467-A4C5-657C87586AFFQ46225983-4FC99575-F7F4-4081-8441-894F01663A47Q47549327-E6967516-F118-4D03-91D5-4771C2C9EF75Q48505037-8893E8A7-B3B3-44BD-84F1-741094DC4F30Q49846193-4E061307-1D83-40EB-BB12-591005D428AEQ52891782-DB28015C-0F1F-4C97-8243-8647385947C6Q58699291-95AA7C76-9610-49B5-89C3-C44764D7AA47
P2860
Effects of sevelamer carbonate on advanced glycation end products and antioxidant/pro-oxidant status in patients with diabetic kidney disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Effects of sevelamer carbonate ...... with diabetic kidney disease.
@ast
Effects of sevelamer carbonate ...... with diabetic kidney disease.
@en
type
label
Effects of sevelamer carbonate ...... with diabetic kidney disease.
@ast
Effects of sevelamer carbonate ...... with diabetic kidney disease.
@en
prefLabel
Effects of sevelamer carbonate ...... with diabetic kidney disease.
@ast
Effects of sevelamer carbonate ...... with diabetic kidney disease.
@en
P2093
P2860
P356
P1476
Effects of sevelamer carbonate ...... with diabetic kidney disease.
@en
P2093
AGE-less Study Group
Elena M Yubero-Serrano
Gary E Striker
Helen Vlassara
Leonid Poretsky
Mark Woodward
P2860
P304
P356
10.2215/CJN.07750814
P577
2015-02-20T00:00:00Z